About 2,180 results
Open links in new tab
Center for Biosimilars®
FDA Approves Second Neupogen Biosimilar, Nivestym - Center for …
FDA Approves Pfizer's Rituximab Biosimilar, Ruxience
FDA Approves Semglee Insulin Glargine as First Interchangeable …
FDA Approves Celltrion's Rituximab Biosimilar, Truxima
Amgen Releases Positive Phase 3 Results for Stelara Biosimilar
European Commission Approves Second Lucentis Biosimilar
An Interview With the AAO About Its Bevacizumab Concerns
FDA Approves Third Trastuzumab Biosimilar, Ontruzant
FDA Approves Amgen's Infliximab Biosimilar, Avsola - Center for …